Textron Q3 2026 Shows Modest Growth, Cash Flow Improves; Valuation Still Stretched

What happened

Textron reported third-quarter 2026 revenue of $3.8 billion, up 4% year-over-year, with adjusted EPS rising to $1.76 from $1.55 and manufacturing cash flow before pension contributions jumping to $418 million from $281 million. These results extend the gradual recovery noted in 2025, with strength in Aviation and Bell offsetting continued weakness in Industrial, though no segment detail was provided in the headline. The stock had been flagged as a potential sell due to trading about 48% above a conservative FCF-based DCF estimate near $58.5 and exposure to cyclical business jet demand and U.S. defense budget risks. While the quarterly cash flow improvement is encouraging, it does not eliminate concerns about a possible normalization in business aviation orders or execution risks in the Industrial segment. Management's focus on backlog conversion, especially the FLRAA and MV-75 programs, remains critical to justifying the current premium valuation.

Implication

For existing holders, the Q3 2026 performance suggests the downside risk is moderating, but the stock still trades well above intrinsic value based on current cash generation. The 49% increase in manufacturing cash flow indicates better operational execution, yet one quarter does not establish a trend, especially given the seasonal nature of aerospace and defense. The ongoing reliance on U.S. defense programs and a potential business jet downcycle remain key overhangs that could pressure earnings if macro conditions deteriorate. Valuation multiples around 18x earnings leave little room for error, so adding to positions at these levels would require a significant re-rating of growth prospects. A more attractive entry point would appear closer to $70-75, where the margin of safety improves, or after clear evidence that FLRAA and Industrial restructuring are delivering sustained improvements.

Thesis delta

The prior stance was a potential sell based on valuation and cyclical risk. Today's results show improving fundamentals, particularly manufacturing cash flow, which reduces the urgency to sell but does not yet support a buy. The thesis shifts from 'potential sell' to 'hold/trim,' with a focus on whether cash flow growth can be sustained and backlog conversion remains on track.